8 | sigma Receptors (sigma Receptor)IBA
01/2019
-
06/2002 |
6 | CalciumIBA
02/2014
-
07/2006 |
4 | 2- ((2- morpholino)ethylthio)- 5- ethoxybenzimidazoleIBA
01/2019
-
10/2011 |
2 | Acid Sensing Ion ChannelsIBA
01/2021
-
07/2010 |
2 | LigandsIBA
11/2016
-
01/2013 |
2 | Glucose (Dextrose)FDA LinkGeneric
02/2014
-
12/2006 |
2 | Tissue Plasminogen Activator (Alteplase)FDA Link
01/2013
-
05/2006 |
2 | Guanidine (Guanidine Nitrate)FDA Link
01/2013
-
03/2010 |
2 | metaphitIBA
10/2011
-
12/2006 |
2 | N- (2- (3,4- Dichlorphenyl)ethyl)- N,N',N'- trimethyl- 1,2- ethandiaminIBA
10/2011
-
12/2006 |
2 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2010
-
12/2006 |
2 | Ion Channels (Ion Channel)IBA
11/2009
-
11/2008 |
1 | Potassium ChlorideFDA LinkGeneric
01/2021 |
1 | Sorafenib (BAY 43-9006)FDA Link
01/2021 |
1 | Bumetanide (Bumex)FDA LinkGeneric
01/2021 |
1 | Carrier Proteins (Binding Protein)IBA
01/2021 |
1 | omega-Chloroacetophenone (Mace)IBA
01/2021 |
1 | Ethacrynic Acid (Etacrynic Acid)FDA Link
01/2021 |
1 | SodiumIBA
01/2021 |
1 | Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
01/2021 |
1 | Apoptosis Regulatory ProteinsIBA
01/2019 |
1 | Caspase 3 (Caspase-3)IBA
01/2019 |
1 | Peptide Hydrolases (Proteases)FDA Link
01/2019 |
1 | Anti-Anxiety Agents (Anxiolytics)IBA
01/2019 |
1 | PotassiumIBA
01/2018 |
1 | Acetylcholine (Acetylcholine Chloride)FDA Link
01/2018 |
1 | MTI-101IBA
01/2017 |
1 | PeptidomimeticsIBA
01/2017 |
1 | S-nitrosocysteineIBA
11/2016 |
1 | benzimidazoleIBA
11/2016 |
1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2016 |
1 | MorpholinosIBA
11/2016 |
1 | 6- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA
02/2014 |
1 | Butylated Hydroxytoluene (BHT)IBA
02/2014 |
1 | phenyl-N-tert-butylnitroneIBA
02/2014 |
1 | AzidesIBA
02/2014 |
1 | Adenosine Triphosphate (ATP)IBA
10/2011 |
1 | Purinergic Receptors (Receptors, Purine)IBA
10/2011 |
1 | 1- (2- (3,4- dichlorophenyl)ethyl)- 4- methylpiperazineIBA
10/2011 |
1 | Bortezomib (Velcade)FDA Link
06/2011 |
1 | Farnesyltranstransferase (Farnesyltransferase)IBA
06/2011 |
1 | tipifarnib (R115777)IBA
06/2011 |
1 | Tetrodotoxin (Tetradotoxin)IBA
07/2010 |
1 | 2-Amino-5-phosphonovalerate (2 Amino 5 phosphonovalerate)IBA
07/2010 |
1 | Protons (Proton)IBA
07/2010 |
1 | Nifedipine (Adalat)FDA LinkGeneric
07/2010 |
1 | IodidesIBA
03/2010 |
1 | CopperIBA
03/2010 |
1 | GuanidinesIBA
03/2010 |
1 | Voltage-Gated Sodium ChannelsIBA
11/2009 |
1 | Potassium Channels (Potassium Channel)IBA
11/2009 |
1 | CatecholaminesIBA
07/2009 |
1 | Prazosin (Minipress)FDA LinkGeneric
07/2009 |
1 | beta Adrenergic ReceptorsIBA
07/2009 |
1 | Carvedilol (Coreg)FDA LinkGeneric
07/2009 |
1 | Pentazocine (Talwin)FDA LinkGeneric
12/2006 |
1 | 2- (4- morpholino)ethyl- 1- phenylcyclohexane- 1- carboxylateIBA
12/2006 |
1 | ethylamineIBA
12/2006 |
1 | piperidineIBA
12/2006 |
1 | Sodium AzideIBA
12/2006 |
1 | carbetapentane (pentoxyverine)IBA
12/2006 |
1 | Ibogaine (Endabuse)IBA
12/2006 |
1 | Sigma-1 ReceptorIBA
12/2006 |
1 | Cocaine (Cocaine HCl)IBA
07/2006 |
1 | Proteins (Proteins, Gene)FDA Link
07/2006 |
1 | KN 62IBA
07/2006 |
1 | Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
07/2006 |
1 | Calcium-Calmodulin-Dependent Protein KinasesIBA
07/2006 |
1 | fluoro jadeIBA
05/2006 |
1 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2004 |